Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 134

1.

Environmental factors in the development of autism spectrum disorders.

Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, Pace DG, Bagasra O.

Environ Int. 2016 Jan 27;88:288-298. doi: 10.1016/j.envint.2015.12.021. [Epub ahead of print] Review.

PMID:
26826339
2.
3.

Thiomersal-containing vaccines - a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(1):59-64, 157-61. Review. English, Polish.

4.

Autism: why the rise in rates?

Zylstra RG, Prater CD, Walthour AE, Aponte AF.

J Fam Pract. 2014 Jun;63(6):316-20. No abstract available.

PMID:
25061621
5.

Autism: 5 misconceptions that can complicate care.

Savoy M.

J Fam Pract. 2014 Jun;63(6):310-4. No abstract available.

PMID:
25061620
6.

Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.

Hooker B, Kern J, Geier D, Haley B, Sykes L, King P, Geier M.

Biomed Res Int. 2014;2014:247218. doi: 10.1155/2014/247218. Epub 2014 Jun 4. Review.

7.

A meta-analysis of the evidence on the impact of prenatal and early infancy exposures to mercury on autism and attention deficit/hyperactivity disorder in the childhood.

Yoshimasu K, Kiyohara C, Takemura S, Nakai K.

Neurotoxicology. 2014 Sep;44:121-31. doi: 10.1016/j.neuro.2014.06.007. Epub 2014 Jun 19. Review.

8.

Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies.

Taylor LE, Swerdfeger AL, Eslick GD.

Vaccine. 2014 Jun 17;32(29):3623-9. doi: 10.1016/j.vaccine.2014.04.085. Epub 2014 May 9.

9.

Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal.

Li X, Qu F, Xie W, Wang F, Liu H, Song S, Chen T, Zhang Y, Zhu S, Wang Y, Guo C, Tang TS.

Toxicol Sci. 2014 Jun;139(2):452-65. doi: 10.1093/toxsci/kfu049. Epub 2014 Mar 27.

10.

Chile votes to ban thiomersal in vaccines despite opposition from doctors and scientists.

Arie S.

BMJ. 2014 Feb 5;348:g1355. doi: 10.1136/bmj.g1355. No abstract available.

PMID:
24500362
11.

[Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].

García-Fernández L, Hernández AV, Suárez Moreno V, Fiestas F.

Rev Peru Med Exp Salud Publica. 2013 Apr;30(2):268-74. Review. Spanish.

12.

Credibility battles in the autism litigation.

Kirkland A.

Soc Stud Sci. 2012 Apr;42(2):237-61.

PMID:
22848999
13.

Thiomersal vaccines debate continues ahead of UN meeting.

Siva N.

Lancet. 2012 Jun 23;379(9834):2328. No abstract available.

PMID:
22734143
14.

The thimerosal insinuation.

Scalzo A, Haller K.

Mo Med. 2012 Jan-Feb;109(1):14-5. No abstract available.

PMID:
22428440
15.

Normal concentrations of heavy metals in autistic spectrum disorders.

Albizzati A, Morè L, Di Candia D, Saccani M, Lenti C.

Minerva Pediatr. 2012 Feb;64(1):27-31.

PMID:
22350041
16.

[Lack of association between thimerosal-containing vaccines and autism].

Mrozek-Budzyn D, Majewska R, Kiełtyka A, Augustyniak M.

Przegl Epidemiol. 2011;65(3):491-5. Polish.

PMID:
22184954
17.

Autism's fight for facts: A voice for science.

Wadman M.

Nature. 2011 Nov 2;479(7371):28-31. doi: 10.1038/479028a. No abstract available.

PMID:
22051658
18.

Addressing the vaccine confidence gap.

Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S.

Lancet. 2011 Aug 6;378(9790):526-35. doi: 10.1016/S0140-6736(11)60678-8. Epub 2011 Jun 12.

PMID:
21664679
19.

Autism and vaccines: search for cause amidst controversy.

Bell J, Abdul-Rahman O, Buttross S.

J Miss State Med Assoc. 2011 Feb;52(2):35-8. No abstract available.

PMID:
21387868
20.

Safety review: squalene and thimerosal in vaccines.

Montana M, Verhaeghe P, Ducros C, Terme T, Vanelle P, Rathelot P.

Therapie. 2010 Nov-Dec;65(6):533-41. Epub 2010 Dec 23. Review.

PMID:
21176760
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk